Terms: = Colorectal cancer AND CASC5, AF15Q14, 57082, ENSG00000137812, D40, Q8NG31
4 results:
1. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of a hybrid automatic planning solution for rectal cancer.
Peng J; Yu L; Xia F; Zhang K; Zhang Z; Wang J; Hu W
Radiat Oncol; 2022 Oct; 17(1):166. PubMed ID: 36229849
[TBL] [Abstract] [Full Text] [Related]
3. Identification of m6A-Related Biomarkers Associated with Prognosis of colorectal cancer.
Zhang Z; Zhang X
Med Sci Monit; 2021 Aug; 27():e932370. PubMed ID: 34373442
[TBL] [Abstract] [Full Text] [Related]
4. Health care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancer.
Hess LM; Zhu YE; Fang Y; Liepa AM
J Med Econ; 2021; 24(1):930-938. PubMed ID: 34289799
[TBL] [Abstract] [Full Text] [Related]
